UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.


Journal

Nuclear medicine communications
ISSN: 1473-5628
Titre abrégé: Nucl Med Commun
Pays: England
ID NLM: 8201017

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 31 5 2019
medline: 26 11 2019
entrez: 31 5 2019
Statut: ppublish

Résumé

The purpose of these guidelines is to assist specialists in Nuclear Medicine and Radionuclide Radiology in recommending, performing, interpreting and reporting F-fluciclovine PET/computed tomography. It should be recognised that adherence to the guidance in this document will not assure an accurate diagnosis or a successful outcome. These guidelines will assist individual departments in the formulation of their own local protocols. The guidelines apply to studies on adults. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources and the needs of the patient in order to deliver effective and safe medical care.

Identifiants

pubmed: 31145206
doi: 10.1097/MNM.0000000000001030
doi:

Substances chimiques

Carboxylic Acids 0
Cyclobutanes 0
fluciclovine F-18 38R1Q0L1ZE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

662-674

Subventions

Organisme : Medical Research Council
ID : MC_PC_16048
Pays : United Kingdom

Auteurs

Asim Afaq (A)

Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust.

Fergus Gleeson (F)

Department of Radiology.

Andrew Scarsbrook (A)

Department of Nuclear Medicine, St James's University Hospital, Leeds.

Kevin Bradley (K)

Department of Radiology.

Manil Subesinghe (M)

King's College London and Guy's and St Thomas' PET Centre, St Thomas' Hospital.
Department of Cancer Imaging KCL School of Biomedical Engineering and Imaging Sciences, London.

Ruth Macpherson (R)

Radiation Physics and Protection, Churchill Hospital, Oxford University Hospitals NHS Trust, Old Road, Oxford.

Athar Haroon (A)

Department of Nuclear Medicine, Barts Health NHS Trust, St Bartholomew's Hospital.

Neel Patel (N)

Department of Radiology.

Sue Chua (S)

Department of Nuclear Medicine and PET/CT, The Royal Marsden Hospital NHS Foundation Trust.

Wai-Lup Wong (WL)

Paul Strickland Scanner Centre, Mount Vernon Hospital.

Sobhan Vinjamuri (S)

Department of Nuclear Medicine, Royal Liverpool University Hospital, Liverpool, UK.

Victoria S Warbey (VS)

King's College London and Guy's and St Thomas' PET Centre, St Thomas' Hospital.
Department of Cancer Imaging KCL School of Biomedical Engineering and Imaging Sciences, London.

Gary J Cook (GJ)

King's College London and Guy's and St Thomas' PET Centre, St Thomas' Hospital.
Department of Cancer Imaging KCL School of Biomedical Engineering and Imaging Sciences, London.

Jamshed Bomanji (J)

Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH